Works by Kusumoto, S.


Results: 25
    1
    2
    3
    4

    FIVE‐YEAR RESULTS OF A PHASE 2 STUDY OF CNS‐ORIENTED THERAPY WITH R‐CHOP FOR UNTREATED INTRAVASCULAR LARGE B‐CELL LYMPHOMA: FINAL ANALYSIS OF THE PRIMEUR‐IVL STUDY.

    Published in:
    Hematological Oncology, 2023, v. 41, p. 46, doi. 10.1002/hon.3163_18
    By:
    • Shimada, K.;
    • Yamaguchi, M.;
    • Kuwatsuka, Y.;
    • Matsue, K.;
    • Sato, K.;
    • Kusumoto, S.;
    • Nagai, H.;
    • Takizawa, J.;
    • Fukuhara, N.;
    • Nagafuji, K.;
    • Miyazaki, K.;
    • Ohtsuka, E.;
    • Okamoto, A.;
    • Uchida, T.;
    • Kayukawa, S.;
    • Wake, A.;
    • Sugita, Y.;
    • Ennishi, D.;
    • Kondo, Y.;
    • Meguro, A.
    Publication type:
    Article
    5
    6
    7

    A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TUCIDINOSTAT (HBI‐8000) IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY ADULT T‐CELL LEUKEMIA‐LYMPHOMA (ATL)

    Published in:
    Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.122_2880
    By:
    • Izutsu, K.;
    • Utsunomiya, A.;
    • Jo, T.;
    • Yoshida, S.;
    • Ando, K.;
    • Choi, I.;
    • Imaizumi, Y.;
    • Kato, K.;
    • Kurosawa, M.;
    • Kusumoto, S.;
    • Miyagi, T.;
    • Ohtsuka, E.;
    • Sasaki, O.;
    • Shibayama, H.;
    • Shimoda, K.;
    • Takamatsu, Y.;
    • Takano, K.;
    • Tsukasaki, K.;
    • Makita, S.;
    • Yonekura, K.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25